Results 361-380 of 1,500 for drugs speaker:Stephen Donnelly

Written Answers — Department of Health: Medicinal Products (14 Feb 2023)

Stephen Donnelly: ...gravidarum is expected to affect about 1% of the pregnant population. The Health Service Executive (HSE) has statutory responsibility for decisions on pricing and reimbursement of medicines under the community drugs schemes, in accordance with the Health (Pricing and Supply of Medical Good s) Act 2013. Only licenced indications which have been granted market authorisation by the European...

Written Answers — Department of Health: Medicinal Products (14 Feb 2023)

Stephen Donnelly: ...gravidarum is expected to affect about 1% of the pregnant population. The Health Service Executive (HSE) has statutory responsibility for decisions on pricing and reimbursement of medicines under the community drugs schemes, in accordance with the Health (Pricing and Supply of Medical Good s) Act 2013. Only licenced indications which have been granted market authorisation by the European...

Written Answers — Department of Health: Medicinal Products (14 Feb 2023)

Stephen Donnelly: ...on an individual patient basis where consultant initiated. Hyperemesis gravidarum is expected to affect about 1% of the pregnant population. There were no applications processed through the Drug Payment Scheme in 2021 and 2022. However, as of 10th February 2023, the number of applications received by the Primary Care Reimbursement Service (PCRS) under the new exceptional...

Written Answers — Department of Health: Healthcare Policy (14 Feb 2023)

Stephen Donnelly: ...diabetes mellitus; parkinsonism; epilepsy; phenylketonuria; haemophilia; spina bifida; hydrocephalus; and conditions arising from the use of Thalidomide. Under the LTI scheme, patients receive drugs, medicines, and medical and surgical appliances directly related to the treatment of their illness, free of charge. All chronic long-term illnesses, including those not covered by the LTI...

Written Answers — Department of Health: Medicinal Products (14 Feb 2023)

Stephen Donnelly: ...gravidarum is expected to affect about 1% of the pregnant population. The Health Service Executive (HSE) has statutory responsibility for decisions on pricing and reimbursement of medicines under the community drugs schemes, in accordance with the Health (Pricing and Supply of Medical Good s) Act 2013. Only licenced indications which have been granted market authorisation by the European...

Written Answers — Department of Health: Medicinal Products (14 Feb 2023)

Stephen Donnelly: ...gravidarum is expected to affect about 1% of the pregnant population. The Health Service Executive (HSE) has statutory responsibility for decisions on pricing and reimbursement of medicines under the community drugs schemes, in accordance with the Health (Pricing and Supply of Medical Good s) Act 2013. Only licenced indications which have been granted market authorisation by the European...

Written Answers — Department of Health: Medicinal Products (14 Feb 2023)

Stephen Donnelly: ...gravidarum is expected to affect about 1% of the pregnant population. The Health Service Executive (HSE) has statutory responsibility for decisions on pricing and reimbursement of medicines under the community drugs schemes, in accordance with the Health (Pricing and Supply of Medical Good s) Act 2013. Only licenced indications which have been granted market authorisation by the European...

Written Answers — Department of Health: Medicinal Products (14 Feb 2023)

Stephen Donnelly: ...HSE Medicines Management Programme, and to address the unmet need of patients with hyperemesis gravidarum, an exceptional arrangement was put in place to support the reimbursement of Cariban®. Cariban® is now available under the community drug schemes – the General Medical Services (GMS) and the Drugs Payment Scheme (DPS) – on an individual patient basis for those...

Written Answers — Department of Health: Medicinal Products (14 Feb 2023)

Stephen Donnelly: ...gravidarum is expected to affect about 1% of the pregnant population. The Health Service Executive (HSE) has statutory responsibility for decisions on pricing and reimbursement of medicines under the community drugs schemes, in accordance with the Health (Pricing and Supply of Medical Goods) Act 2013. Only licenced indications which have been granted market authorisation by the...

Written Answers — Department of Health: Medicinal Products (14 Feb 2023)

Stephen Donnelly: ...gravidarum is expected to affect about 1% of the pregnant population. The Health Service Executive (HSE) has statutory responsibility for decisions on pricing and reimbursement of medicines under the community drugs schemes, in accordance with the Health (Pricing and Supply of Medical Good s) Act 2013. Only licenced indications which have been granted market authorisation by the European...

Written Answers — Department of Health: Medicinal Products (14 Feb 2023)

Stephen Donnelly: ...given the uncertainty around new variants, and the current evolutionary pattern towards sub-lineages of Omicron strains. The European Medicines Agency’s Emergency Task Force and the U.S. Food and Drug Administration have outlined concerns around the declining efficacy of these treatments and have cautioned that monoclonal antibodies currently authorised for COVID-19, including...

Written Answers — Department of Health: Medicinal Products (14 Feb 2023)

Stephen Donnelly: ...gravidarum is expected to affect about 1% of the pregnant population. The Health Service Executive (HSE) has statutory responsibility for decisions on pricing and reimbursement of medicines under the community drugs schemes, in accordance with the Health (Pricing and Supply of Medical Good s) Act 2013. Only licenced indications which have been granted market authorisation by the European...

Written Answers — Department of Health: Health Services (14 Feb 2023)

Stephen Donnelly: ...diabetes mellitus; parkinsonism; epilepsy; phenylketonuria; haemophilia; spina bifida; hydrocephalus; and conditions arising from the use of Thalidomide. Under the LTI scheme, patients receive drugs, medicines, and medical and surgical appliances directly related to the treatment of their illness, free of charge. While there are no plans currently to extend the list of illnesses...

Written Answers — Department of Health: Medicinal Products (14 Feb 2023)

Stephen Donnelly: ...gravidarum is expected to affect about 1% of the pregnant population. The Health Service Executive (HSE) has statutory responsibility for decisions on pricing and reimbursement of medicines under the community drugs schemes, in accordance with the Health (Pricing and Supply of Medical Goods) Act 2013. Only licenced indications which have been granted market authorisation by the European...

Written Answers — Department of Health: Medicinal Products (14 Feb 2023)

Stephen Donnelly: As the Health Service Executive (HSE) has statutory responsibility for decisions on pricing and reimbursement of medicines under the community drugs schemes, in accordance with the Health (Pricing and Supply of Medical Goods) Act 2013, I have asked HSE to respond to the Deputy directly as soon as possible.

Written Answers — Department of Health: Medicinal Products (9 Feb 2023)

Stephen Donnelly: ...gravidarum is expected to affect about 1% of the pregnant population. The Health Service Executive (HSE) has statutory responsibility for decisions on pricing and reimbursement of medicines under the community drugs schemes, in accordance with the Health (Pricing and Supply of Medical Good s) Act 2013. Only licenced indications which have been granted market authorisation by the European...

Written Answers — Department of Health: Medicinal Products (9 Feb 2023)

Stephen Donnelly: The Health Service Executive (HSE) has statutory responsibility for decisions on pricing and reimbursement of medicines under the community drug schemes, in accordance with the Health (Pricing and Supply of Medical Goods) Act 2013. Therefore, I have asked the HSE to respond to the Deputy directly, as soon as possible.

Written Answers — Department of Health: Medicinal Products (9 Feb 2023)

Stephen Donnelly: ...gravidarum is expected to affect about 1% of the pregnant population. The Health Service Executive (HSE) has statutory responsibility for decisions on pricing and reimbursement of medicines under the community drugs schemes, in accordance with the Health (Pricing and Supply of Medical Good s) Act 2013. Only licenced indications which have been granted market authorisation by the European...

Written Answers — Department of Health: Medicinal Products (9 Feb 2023)

Stephen Donnelly: ...Exempt Medicinal Product, has now been made available on an individual patient basis for those patients who meet the criteria and where Consultant Obstetrician initiated. Under the community drug schemes, Exempt Medicinal Products must be Consultant initiated. However, whilst the original prescriber of Cariban® must be a consultant and specialist in the relevant field, the HSE will...

Written Answers — Department of Health: Medicinal Products (9 Feb 2023)

Stephen Donnelly: ...gravidarum, a severe form of morning sickness, during pregnancy. The Health Service Executive (HSE) has statutory responsibility for decisions on pricing and reimbursement of medicines under the community drugs schemes, in accordance with the Health (Pricing and Supply of Medical Goods) Act 2013. Only licenced indications which have been granted market authorisation by the European...